Agios Pharmaceuticals, Inc. (AGIO) reported earnings of $16.22 per share for the third quarter of 2024, which missed the Zacks Consensus Estimate of $16.69. In the year-ago quarter, the company had reported a loss of $1.64 per share.The abovementioned earnings included a gain on the sale of contingent payments and a milestone payment from a gain on the sale of the oncology business. Excluding these items, the company incurred a loss of 15 cents per share.Earnings grew significantly year over year owing to a ...